Biobanking and Biomolecular Resources Research Infrastructure

akronüüm: BBMRI
algus: 2008-02-01
lõpp: 2011-01-31
 
programm: FP7 - Euroopa Liidu 7. raamprogramm
alaprogramm: INFRA - Teadustöö infrastruktuurid
instrument: CP-CSA-INFRA - Koostööprojekt - koordineeritud toetavad tegevused - INFRA
projektikonkurss: FP7-INFRASTRUCTURES-2007-1
projekti number: 212111
kestus kuudes: 36
partnerite arv: 54
 
lühikokkuvõte: The Preparatory Phase for a pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) will focus on technical, legal, governance, and financial issues to • prepare to construct BBMRI, building on existing biobanks, resources and technologies, specifically complemented with innovative components and properly embedded into European scientific, ethical, legal and societal frameworks, • provide the concept for a key resource to increase excellence and efficacy in biomedical sciences, drug development and public health, • expand and secure competitiveness of European research and industry in a global context, • develop a sustainable financial framework. Biomedical quality-assessed samples and data as well as biomolecular resources and molecular analysis tools are essential for academic and industry-driven research to treat and prevent human diseases. Although currently established national biobanks and biomolecular resources are a unique European strength, valuable collections typically suffer from fragmentation of the European biobanking-related research community. This hampers the collation of biological samples and data from different biobanks required to achieve sufficient statistical power. Moreover, it results in duplication of effort and jeopardises sustainability due to the lack of long-term funding. BBMRI will comprise: • biobanks of different formats (collections of blood, DNA, tissue, etc., together with medical, environmental, life-style and follow-up data), • biomolecular resources (antibody and affinity binder collections, ORF clone collections, siRNA libraries, proteins, cellular resources etc.), • enabling technologies and high-throughput analysis platforms and molecular tools to decipher gene, protein and metabolite functions and their interactions, • harmonized standards for sample collection, storage, preanalytics and analysis • harmonized databases and biocomputing infrastructure, • ethical, legal and societal
partneri jrk nr ja roll partneri nimi riik kontaktisik koduleht
1 koordinaator Medizinische Universitaet Graz AT Michaela Mayrhofer http://www.medunigraz.at
2 partner TERVEYDEN JA HYVINVOINNIN LAITOS FI Jaakko Penttinen http://www.thl.fi
3 partner HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH DE Juergen Ertel http://www.helmholtz-muenchen.de
4 partner UPPSALA UNIVERSITET SE Ulf Boox http://www.uu.se
5 partner KAROLINSKA INSTITUTET SE Jan-Eric Grahn http://www.ki.se
6 partner INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) FR Karine Lanini http://www.inserm.fr
7 partner THE UNIVERSITY OF MANCHESTER UK Liz Fay http://www.manchester.ac.uk
8 partner CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER FR Markus Pasterk http://www.iarc.fr
9 partner ACADEMISCH ZIEKENHUIS LEIDEN - LEIDS UNIVERSITAIR MEDISCH CENTRUM NL Linda Ouwerkerk http://www.lumc.nl
10 partner UNIVERSITA TA MALTA MT Alex Felice http://www.um.edu.mt
11 partner NTNU - NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NO Kristian Hveem http://www.ntnu.no
12 partner SEMMELWEIS EGYETEM HU András Falus http://www.sote.hu
13 partner Tartu Ülikool EE Andres Metspalu http://www.ut.ee
14 partner UNIVERSIDAD DE SALAMANCA ES Fernando Pérez Barriocanal http://www.usal.es
15 partner FONDAZIONE TELETHON IT Lucia Mearelli http://www.telethon.it
16 partner FEDERATION HOSPITALIERE DE FRANCE FR Gérard Vincent
17 partner MOLECULAR MEDICINE IRELAND LBG IE Margaret Cooney http://www.molecularmedicineireland.ie
18 partner HERMANN VON HELMHOLTZ-GEMEINSCHAFT DEUTSCHER FORSCHUNGSZENTRUM EV DE Tania Lieckweg http://www.helmholtz.de
19 partner INSTITUT NATIONAL DU CANCER FR Michel Ledain http://www.e-cancer.fr
20 partner PRESIDENZA DEL CONSIGLIO DEI MINISTRI. IT Agnese Camilli http://www.governo.biotecnologie.it
21 partner MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. DE Joachim Gerlach http://www.mpg.de
22 partner INSTITUTO DE SALUD CARLOS III ES Tomas Fraile http://www.isciii.es
23 partner VITRO S.A. ES Pablo Bustamante
25 partner EUROPEAN MOLECULAR BIOLOGY LABORATORY DE Keith Williamson http://www.embl.org
27 partner NASJONALT FOLKEHELSEINSTITUTT NO Kristian Hveem http://www.fhi.no
28 partner ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL Paula De Bruin http://www.erasmusmc.nl
29 partner IRCCS AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO-IST-ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO IT Piera Castagnacci http://www.hsanmartino.it
30 partner CONSIGLIO NAZIONALE DELLE RICERCHE IT Maria Giovanna Torti http://www.cnr.it
31 partner THE HEALTH RESEARCH BOARD IE Anne Cody http://www.hrb.ie
32 partner MEDICAL RESEARCH COUNCIL UK Deborah Stephens http://www.mrc.ac.uk
33 partner UK BIOBANK LIMITED UK Timothy Peakman http://www.ukbiobank.ac.uk
34 partner MINISTERIE VAN ONDERWIJS, CULTUUR EN WETENSCHAP NL Richard Derksen
35 partner THE ICELANDIC CENTRE FOR RESEARCH IS Rebekka Valsdottir http://www.rannis.is
36 partner ACADEMISCH ZIEKENHUIS GRONINGEN NL Ben W. Verwey http://www.umcg.nl
37 partner NEDERLANDSE FEDERATIE VAN UNIVERSITAIR MEDISCH CENTRA NL Dink A Legemate http://www.nfu.nl
38 partner ZORGONDERZOEK NEDERLAND ZON NL Richard Beekum http://www.ZONMW.NL
39 partner FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V DE Andrea Zeumann http://www.fraunhofer.de
40 partner BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG DE Ingrid Zwoch http://www.bmbf.de
41 partner BUNDESMINISTERIUM FUR WISSENSCHAFT UND FORSCHUNG BMWF AT Reinhard Klang http://www.bmwf.gv.at
43 partner ISLENSK ERFDAGREINING EHF IS Gudmundu Einarsson http://www.decode.com
44 partner LIFE SCIENCE GOVERNANCE INSTITUTE AT Herbert Gottweis http://www.lsgi.eu
46 partner CARDIFF UNIVERSITY UK Ruth Bodycombe http://www.cardiff.ac.uk
47 partner ALLEANZA CONTRO IL CANCRO IT Cristina Venturini http://www.alleanzacontroilcancro.it
49 partner FUNDACION PARA EL DESAROLLO DE LA INVESTIGACION EN GENOMICA Y PROTEOMICA ES Nieves Sala
50 partner Haridus- ja Teadusministeerium EE Indrek Reimand http://www.hm.ee
51 partner BABRAHAM BIOSCIENCE TECHNOLOGIES LIMITED UK Becky Paxton
52 partner MINISTRY OF DEVELOPMENT, COMPETITIVENESS, INFRASTRUCTURE, TRANSPORT AND NETWORKS EL Aikaterini Galanou
53 partner BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS EL Dimitris Raptis http://www.bioacademy.gr
54 partner UNIVERSITAET KLAGENFURT AT Johann Eder http://www.uni-klu.ac.at
55 partner TURUN YLIOPISTO FI Eliisa Särkilahti
56 partner LEGAL PATHWAYS BV NL Jasper Bovenberg http://www.legalpathways.eu
57 partner IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE IE Eibhlin Mulroe http://www.ipposi.ie
58 partner MERIEUX ALLIANCE SA FR Nicole Lemarchand http://www.biomerieux.com/servlet/srt/bio/portail/dynPage?lang=fr&node=Merieux_Alliance
59 partner INTERNATIONAL PREVENTION RESEARCH INSTITUT-IPRI MANAGEMENT FR Peter Boyle